Skip to main content

Parkinson’s deep brain target fired up

Oct. 5, 2011, 11:54 AM

brain
(iStock)

Parkinson’s disease is a neurodegenerative disorder marked by progressive loss of motor control. Evidence from animal models suggests that increased neuronal activity in a region of the brain called the subthalamic nucleus may play a role in the pathophysiology of the disorder. For this reason, the subthalamic nucleus is a common target for deep brain stimulation (DBS) – an FDA-approved therapy for advanced Parkinson’s disease.

Peter Konrad, associate professor of neurological surgery, and colleagues are conducting a pilot clinical trial to test DBS in individuals with early-stage Parkinson’s disease. This trial provides the team with a unique opportunity to evaluate neuronal activity in the subthalamic nucleus in early-stage disease (prior to this trial, such recordings have only been possible in patients undergoing DBS for advanced disease).

They report in Movement Disorders that subthalamic nucleus neurons had a significantly lower firing rate – and the region had lower overall activity – in early versus advanced Parkinson’s disease. The findings suggest that neuronal firing in the subthalamic nucleus increases with disease progression.

This study was supported by Medtronic, Inc., the National Center for Research Resources, and the Parkinson’s and Movement Disorder Foundation.

Recent Stories from VUMC News and Communications Publications

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

Vanderbilt Medicine

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

A diagnosis of cancer at any age is tragic, but during the adolescent and young adult years, it’s especially complicated.

Hope

A diagnosis of cancer at any age is tragic, but during the adolescent and young adult years, it’s especially complicated.

Karen Dyer Young cares for patients and members of the Dayani Center who have or are recovering from cancer or a stem cell transplant.

Momentum

Karen Dyer Young cares for patients and members of the Dayani Center who have or are recovering from cancer or a stem cell transplant.

more